Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Morten Ladekarl

Showing results (1-10 of 75) with videos related to

Pageof 8
Sort By:
Chinese Clinical Oncology|March 13, 2023
Pembrolizumab for second line treatment of advanced hepatocellular carcinoma-who would benefit?Morten Ladekarl
Analytical and Quantitative Cytology and Histology|May 11, 2004
Choice of methodology for quantifying cancer structures in tissue sections. A comparison of 2- and 3-dimensional estimators of mitotic activity, cellularity and nuclear size in breast cancerMorten Ladekarl
Current Oncology (Toronto, Ont.)|February 26, 2026
Characteristics, Prognosis and Reasons for Opting-Out of Treatment in Patients with Untreated Pancreatic CancerMorten Ladekarl, Mogens Tornby Stender
Ugeskrift for Laeger|May 7, 2010
[Oncological treatment of patients with pancreatic cancer]Morten Ladekarl, Benny Vittrup Jensen, Per Pfeiffer
Annals of Surgical Oncology|November 2, 2023
Impact on Survival of Early Versus Late Initiation of Adjuvant Chemotherapy After Pancreatic Adenocarcinoma Surgery: A Target Trial EmulationJakob Kirkegård, Morten Ladekarl, Andrea Lund, et al.
Danish Medical Journal|May 13, 2014
Danish experiences with FOLFIRINOX as first-line therapy in patients with inoperable pancreatic cancerPia Charlotte Kræmer, Hjørdis Hjalting Schmidt, Morten Ladekarl
Clinical Epidemiology|November 9, 2016
Danish Pancreatic Cancer DatabaseClaus Fristrup, Sönke Detlefsen, Carsten Palnæs Hansen, et al.
BMC Cancer|June 7, 2024
Diagnostic accuracy and clinical value of [68Ga]Ga-FAPI-46 PET/CT for staging patients with ovarian cancer: study protocol for a prospective clinical trialMorten Bentestuen, Morten Ladekarl, Aage Knudsen, et al.
The British Journal of Surgery|November 25, 2023
Effect of adjuvant chemotherapy after pancreatectomy in patients with node-negative pancreatic cancer: target trial emulationJakob Kirkegård, Morten Ladekarl, Ida Ravnsbæk Johannsen, et al.
Ugeskrift for Laeger|October 20, 2012
[Danish Pancreatic Cancer Database]Claus Fristrup, Carsten Palnæs Hansen, Morten Ladekarl, et al.
Pageof 8

Showing results (1-10 of 75) with videos related to

Sort By:
Pageof 8
Chinese Clinical Oncology|March 13, 2023
Pembrolizumab for second line treatment of advanced hepatocellular carcinoma-who would benefit?Morten Ladekarl
Analytical and Quantitative Cytology and Histology|May 11, 2004
Choice of methodology for quantifying cancer structures in tissue sections. A comparison of 2- and 3-dimensional estimators of mitotic activity, cellularity and nuclear size in breast cancerMorten Ladekarl
Current Oncology (Toronto, Ont.)|February 26, 2026
Characteristics, Prognosis and Reasons for Opting-Out of Treatment in Patients with Untreated Pancreatic CancerMorten Ladekarl, Mogens Tornby Stender
Ugeskrift for Laeger|May 7, 2010
[Oncological treatment of patients with pancreatic cancer]Morten Ladekarl, Benny Vittrup Jensen, Per Pfeiffer
Annals of Surgical Oncology|November 2, 2023
Impact on Survival of Early Versus Late Initiation of Adjuvant Chemotherapy After Pancreatic Adenocarcinoma Surgery: A Target Trial EmulationJakob Kirkegård, Morten Ladekarl, Andrea Lund, et al.
Danish Medical Journal|May 13, 2014
Danish experiences with FOLFIRINOX as first-line therapy in patients with inoperable pancreatic cancerPia Charlotte Kræmer, Hjørdis Hjalting Schmidt, Morten Ladekarl
Clinical Epidemiology|November 9, 2016
Danish Pancreatic Cancer DatabaseClaus Fristrup, Sönke Detlefsen, Carsten Palnæs Hansen, et al.
BMC Cancer|June 7, 2024
Diagnostic accuracy and clinical value of [68Ga]Ga-FAPI-46 PET/CT for staging patients with ovarian cancer: study protocol for a prospective clinical trialMorten Bentestuen, Morten Ladekarl, Aage Knudsen, et al.
The British Journal of Surgery|November 25, 2023
Effect of adjuvant chemotherapy after pancreatectomy in patients with node-negative pancreatic cancer: target trial emulationJakob Kirkegård, Morten Ladekarl, Ida Ravnsbæk Johannsen, et al.
Ugeskrift for Laeger|October 20, 2012
[Danish Pancreatic Cancer Database]Claus Fristrup, Carsten Palnæs Hansen, Morten Ladekarl, et al.
Pageof 8